People · Operator
Named in public records as an officer, director or promoter · active 2022–2022 · Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Khiron Life Sciences Corp. | — | Other | Series A | $10.8M | $8.1M | 2022 |
Chris Naprawa at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Chris Naprawa on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Swapan Kakumanu | 1 | 4 |
| Joel Friedman | 1 | 3 |
| TEJINDER VIRK | 1 | 2 |
| Vicente Fox | 1 | 1 |
| Alvaro Yanez | 1 | 1 |
| Alvaro Torres | 1 | 1 |
| Juan Carlos Echeverry | 1 | 1 |
| Deborah Rosati | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.